13F

Stock

Lantern Pharma Inc.

LTRN · held by 32 managers

Reported value

$2.83M

Holders

32

+2 new · −4 exited

Holders’ est. mark

−$2.69M

Price effect on 27 books still in the name

Largest holder

$1.18M

BIOS Capital Management, LP

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BIOS Capital Management, LP864.4K$1.18M−$1.43MCut−$1.87M
VANGUARD CAPITAL MANAGEMENT LLC332.1K$454.9KHeld
CM Management, LLC250K$342.5K−$373.5KCut−$339.3K
Renaissance Technologies116K$158.9K−$183.3KCut−$175.6K
GEODE CAPITAL MANAGEMENT, LLC111.6K$153K−$160.6KCut−$140.2K
Westside Investment Management, Inc.50K$68.6K−$59.6KCut−$40.2K
Voss Capital, LP50K$68.5K−$83KCut−$83K
VANGUARD FIDUCIARY TRUST CO49.6K$68KHeld
BlackRock, Inc.45.3K$62K−$73.5KCut−$72.1K
DIMENSIONAL FUND ADVISORS LP38.1K$52.1K−$63.2KCut−$66.4K
HORIZON KINETICS ASSET MANAGEMENT LLC26.4K$36.1K−$43.8KCut−$47.4K
DAVENPORT & Co LLC23.8K$32.6K−$39.5KCut−$39.5K
State Street23.7K$32.4K−$39.3KCut−$39.3K
Bank of New York Mellon Corp21.3K$29.2K−$35.4KCut−$51.1K
NORTHERN TRUST CORP15.6K$21.4K−$25.9KCut−$25.9K
Focus Partners Wealth15.4K$21.1K−$25.6KCut−$27.3K
Cetera Investment Advisers12.2K$16.8K−$20.3KCut−$20.3K
UBS Group AG10.1K$13.8K−$16.7KCut−$18.4K
Tower Research Capital LLC (TRC)3.57K$4.89K−$1.4KAdded$2.34K
Vanguard Global Advisers, LLC2.35K$3.23KHeld
SBI Securities Co., Ltd.2.14K$2.94K−$3.56KCut−$3.56K
CURIO WEALTH, LLC2K$2.74K−$3.94KCut−$3.94K
WELLS FARGO & COMPANY/MN1.48K$2.02K−$2.45KCut−$2.45K
MORGAN STANLEY601$823−$998Cut−$998
Fidelity500$685New
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO500$685−$830Cut−$830
OSAIC HOLDINGS, INC.220$301−$357Cut−$350
SIMPLEX TRADING, LLC107$146−$178Cut−$6.69K
JPMORGAN CHASE & CO97$120−$124Cut−$89
CITIGROUP INC45$62New
GROUP ONE TRADING LLC23$32−$38Cut−$12.3K
Key Financial Inc2$3−$3Cut−$3

Who left

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.